Biogen products list. For product information for other countries, please visit your country's Biogen affiliate website. 16 hours ago · BIIB's $5. S. 6 billion, with an upfront payment of $41. In other recent news, Biogen announced its acquisition of Apellis Pharmaceuticals for $5. . 1 day ago · Acquisition is expected to bolster Biogen’s near and long-term growth prospects, adding immediate revenue from two products with significant growth potential; 2025 net product revenue for EMPAVELI ® and SYFOVRE ® together was $689 million, expected to grow at a rate in the mid-to-high teens at least through 2028 2 days ago · Biogen Safe Harbor This news release contains forward-looking statements, including, among others, relating to: the potential benefits, efficacy and safety of a High Dose Regimen of SPINRAZA ® (nusinersen); the potential to advance care and improve outcomes for, and address unmet needs of, patients with SMA; potential regulatory discussions 1 day ago · Significant opportunity to realize product potential through combined commercialization capabilities Transaction is expected to be increasingly accretive starting in 2027 and to strengthen Biogen’s near- and long-term growth potential Transaction is expected to generate a meaningful increase in Biogen’s non-GAAP 16 hours ago · Biogen expects the acquired products to grow in the mid to high teens at least through 2028 and anticipates the deal will be accretive in 2027, though that includes some cost optimization. Oct 21, 2025 · AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive… Get a list of all medicines and other products manufactured by Biogen Healthcare. 6B offer to acquire APLS is set to add two key immunology drugs, boosting near-term revenues and strengthening its push into high-growth rare disease markets. 00 per share in cash. The below information is intended for U. Medications listed here may also be marketed under different names in different countries. Last Updated: January 15, 2026. Biogen Inc. Discover key products and brands of Biogen, including product categories, recent launches, and detailed insights. Jan 15, 2026 · Our medicines aim to improve the well-being of people around the world. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. [2] View Biogen products for Multiple Sclerosis, Spinal Muscular Atrophy & Biosimilars Apr 25, 2023 · Biogen Inc. 16 hours ago · These products generated a combined revenue of US$689 million in 2025, with growth projected in the mid-to-high teens through 2028. The deal also aligns with Biogen’s strategy to expand its presence in nephrology, leveraging Apellis’ expertise and capabilities to strengthen its offerings in immune-mediated diseases. 1mg. residents only. manufactures, markets and/or distributes more than 15 drugs in the United States. Below is a list of our company's therapies. com helps its user by providing a complete list of product manufacture by Biogen Healthcare 1 day ago · The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts. afwjy nmlzj tnaghz xfywmye smtw